Results 91 to 100 of about 1,842 (159)

Successful treatment of palmoplantar pustulosis with topical ruxolitinib. [PDF]

J Dtsch Dermatol Ges
Cramer N, Wellmann P, Schön MP, Mössner R.   +3 more
europepmc   +1 more source

[A palmoplantar pustulosis].

The Pan African medical journal, 2015
Faida, Ajili, Imen, Gharsallah
openaire   +1 more source

Bimekizumab plus topical photochemotherapy effective in palmoplantar pustulosis in a patient with hidradenitis suppurativa. [PDF]

J Dtsch Dermatol Ges
Cramer N, Mohr J, Schön MP, Mössner R.
europepmc   +1 more source

Ultraviolet A1-LED Phototherapy for the Treatment of Palmoplantar Pustulosis. [PDF]

Photodermatol Photoimmunol Photomed
Watanabe O, Enomoto Y, Sakurai M, Sakaida T, Yamamoto A, Morita A.   +5 more
europepmc   +1 more source

Hypopyon Sign in Acral Lesions: Dermoscopic Findings of a Patient with Palmoplantar Pustulosis. [PDF]

Curr Health Sci J
Yorulmaz A.
europepmc   +1 more source

A case of relapsing polychondritis with palmoplantar pustulosis

Indian Journal of Dermatology, 2016
Won Joo Kwon, Min Seok Kim, Jun Yeong Park, Eun Byul Cho, Eun Joo Park, Kwang Ho Kim, Kwang Joong Kim   +6 more
openaire   +3 more sources

Deucravacitinib for the treatment of moderate-to-severe palmoplantar pustulosis: Results from an early-terminated open-label trial. [PDF]

JAAD Int
Ramessur R, Chiesa Fuxench ZC, Shin D, Mason JB, Mason AC, Papadopoulos M, de Oliveira Wafae BG, Noe MH, Gelfand JM.   +8 more
europepmc   +1 more source

Palmoplantar pustulosis.

JIBI INKOKA TEMBO, 1994
openaire   +1 more source

Th17 cells with regulatory phenotype are the main IL-17F and IL-26 producers in palmoplantar pustulosis. [PDF]

JCI Insight
Do TH, Bogle R, Zhang H, Xing X, Gharaee-Kermani M, Raducu M, Fox J, Jiang R, Plazyo O, Harms PW, Nakamura M, Xing E, Gilliet M, Billi AC, Kahlenberg JM, Modlin RL, Uluckan O, Tsoi LC, Gudjonsson JE.   +18 more
europepmc   +1 more source

Emerging Therapies for Palmoplantar Pustulosis with a Focus on IL-23 Inhibitors. [PDF]

J Clin Med
Nam KH, Kim YS.
europepmc   +1 more source